Moneycontrol
HomeNewsTrendsSania Maskatiya and how a luxury fashion label stays relevant in the pandemic
Trending Topics

Sania Maskatiya and how a luxury fashion label stays relevant in the pandemic

Not even a pandemic could dampen the future-oriented outlook of famed fashion designer Sania Maskatiya, who has taken Pakistani crafts to New York runways.

March 27, 2021 / 09:37 IST
Story continues below Advertisement
Sania Maskatiya's Beirut Fashion Week.

March 2020 marked the third year in a row that Sania Maskatiya showcased her designs at New York Fashion Week (NYFW). Days after her show, the pandemic struck the luxury industry worldwide and the lockdown in her hometown Karachi put a spanner in her operations as well.

But the woman considered Pakistan’s most successful fashion export wasn’t one to give up so easily. “How does a luxury fashion brand stay relevant in such times when no one can leave home or dress up for an occasion?” the 37-year-old creative head of her eponymous label brainstormed with her team of 15 designers.

Story continues below Advertisement

Umair Tabani, Sara Tabani, Yacoob Tabani, Sania Maskatiya and Yasmeen Tabani pose for an image.

After all, they had almost 700 workers and artisans across Pakistan whom they needed to keep gainfully employed; they couldn’t just let production come to a halt.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show